Increasing prevalence of infectious disease is predominantly augmenting the growth of the recombinant vaccines market

 


Recombinant
vaccines are made by expressing live viruses as proteins and then creating DNA
sequences out of these viruses. The proteins, or nucleic acid strands, of the
virus, have been repaired with a polymerase that creates a piece of DNA
identical to the rest of the viruses'. These DNA fragments, or polymers, are
injected into the body of a susceptible individual, usually in a vein or in a
garage, through the vein wall. This protects the patient against the deadly
infection caused by the virus. Most commonly used vaccines require one dose of
a product and one dose of a vaccine mixture. This is called a single dose
schedule.



The high prevalence of infectious diseases around the globe is driving the recombinant
vaccines market growth. According to the World Health Organization,
infectious diseases kill over 17 million people a year. An increasing number of
the manufacturer in the recombinant vaccines market is again propelling the
growth of the market. Moreover, advancement in the development of technologies
used in the production of vaccines is further anticipated to foster the growth
of the recombinant vaccines market. Furthermore, continuous investment in
research & development for the production of new vaccines are projected to
fuel the growth of recombinant vaccines.



North
America is projected to gain significant growth over the forecast period and
this is attributed to the high prevalence of the infectious disease in the
region. According to the National Center for Health Statistics, there were
around new tuberculosis cases: 9,105, new salmonella cases: 54,285, new Lyme
disease cases: 42,743, and new meningococcal disease cases: 353 in 2017.



Key
Developments:



1.      In June
2020, Johnson & Johnson announced that through its Janssen Pharmaceutical
Companies (Janssen) it has accelerated the initiation of the Phase 1/2a
first-in-human clinical trial of its investigational SARS-CoV-2 vaccine,
Ad26.COV2-S, recombinant.



2.      In November
2020, The European Commission has granted marketing authorization for
Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the
prevention of influenza in adults aged 18 years and older. Supemtek is the
first and only recombinant influenza vaccine now approved in the European Union.



3.      In February
2020, scientists from Hong Kong and Macao special administrative regions
announced a breakthrough in developing a recombinant COVID-19 vaccine
indicating that the mass production of the vaccine is feasible at a low cost in
the future.

Comments

Post a Comment

Popular posts from this blog

The Global Gynecological Devices Market Continues To Grow Owing To The Rising Demand For Regular Gynecological Checkups And Increasing Awareness On Women’s Health And Hygiene

Image
  A gynecological device is a medical device that is used to promote female health or to protect and preserve reproductive health for females. This is a very broad category and includes products such as watches, calculators, bandages, and hygienic towels. While many of these products have been clinically tested and found to be safe for female health, there are still a few devices in the market that pose threats to female reproductive health. Gynecological devices are usually fall into three categories: medical devices, biological safety devices, and mechanical devices. Medical devices are those that prevent the risk of injury or trauma to a woman's reproductive organs from medical interventions. Biologic safety devices are those that protect a female's health by promoting female reproductive health. Finally, mechanical devices are those that help maintain a woman's reproductive health and allow her to achieve or reach their desired fertility or pregnancy. The use of any of ...
Read more

Polyethylene Terephthalate Market Continues to Expand as British Petroleum plc signs a cooperation agreement with China Resources Chemical Materials Technology Co. Ltd to strengthen cooperation on PTA sourcing

Image
  PET is an abbreviation for polyethylene terephthalate; the material most often used in PET bottles. PET is an extremely tough plastic, which is why it's commonly used as a packaging material. PET has many advantages over other plastics, including strength, resistance to breaking and crushing, and its natural plasticity it will fill almost anything and is resistant to oil and chemicals that can cause it to break down over time. Rapid growth of the food and beverage industry is expected to drive of the global polyethylene terephthalate market growth . The food and beverage industry has witnessed significant growth in both developed and emerging economies. According to the Food and Drink Federation, the U.K., the food and drink manufacturing sector accounts for 17% in terms of economic contribution. Furthermore, according to the India Brand Equity Foundation (IBEF), the food processing industry contributed 14% of the country’s GDP in 2016. Polyethylene terephthalate or PET is widely...
Read more

Stomach Cancer Drugs Market Continues to Expand as South Korean Drug Manufacturer Celltrion Inc. Receives the WHO Prequalification Standards for its biosimilar

Image
  Stomach cancer is a growth of abnormal tissues that form a tumor in the part of your abdomen. Symptoms of stomach cancer often include persistent abdominal pain, extreme heartburn, extreme vomiting, severe indigestion, abdominal swelling, and frequent diarrhea. These symptoms are common for all forms of stomach cancer but when cancer spreads to the upper part of the chest, the symptoms become far more severe and may eventually cause death. Stomach cancer has the highest survival rate of any type of cancer in the world.  Crocetin (trade name Eulexin) is the first Stomach Cancer Drug that is used in the treatment of gastric cancer. It was later on approved for treating peritoneal mesothelioma but was not marketed extensively due to its negative outcomes at the beginning. Increasing prevalence of stomach cancer is expected to drive growth of the global stomach cancer drugs market during the forecast period. According to the American Cancer Society (ACS), in 2020, around 27,600...
Read more